文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于泊洛沙姆的药物递送系统:实体肿瘤治疗的前沿领域。

Poloxamer-based drug delivery systems: Frontiers for treatment of solid tumors.

作者信息

Pourbakhsh Mehdi, Jabraili Masoud, Akbari Morteza, Jaymand Mehdi, Jahanban Esfahlan Rana

机构信息

Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Mater Today Bio. 2025 Apr 2;32:101727. doi: 10.1016/j.mtbio.2025.101727. eCollection 2025 Jun.


DOI:10.1016/j.mtbio.2025.101727
PMID:40275957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12018049/
Abstract

Pluronics or poloxamers are a type of triblock copolymer. These non-ionic molecules consist of a hydrophobic block embedded in two hydrophilic parts. Pluronics have become favorite materials for use in the field of biomedical research due to having favorable physicochemical and biological properties such as amphiphilicity, solubility in ionic and non-ionic solutions, biocompatibility, biodegradability, self-assembly and low toxicity. The scope of these applications can vary from tissue engineering to drug delivery. One of the important uses of pluronics is to deliver drugs to various cancer cells. Herein we first provide an overview on variety of ploronic biomaterials. And then intensively evaluate their potential as drug delivery systems (DDSs) for treatment of solid tumors with special focus on breast cancers. After explaining the pros and cons of pluronics, the current status in clinical settings and future prospects are highlighted.

摘要

普朗尼克(Pluronics)或泊洛沙姆(poloxamers)是一种三嵌段共聚物。这些非离子分子由嵌入两个亲水性部分之间的疏水性嵌段组成。由于具有两亲性、在离子和非离子溶液中的溶解性、生物相容性、生物降解性、自组装性和低毒性等良好的物理化学和生物学特性,普朗尼克已成为生物医学研究领域中备受青睐的材料。这些应用的范围可以从组织工程到药物递送。普朗尼克的重要用途之一是将药物递送至各种癌细胞。在此,我们首先概述各种普朗尼克生物材料。然后深入评估它们作为治疗实体瘤,尤其是乳腺癌的药物递送系统(DDSs)的潜力。在解释了普朗尼克的优缺点之后,突出了其在临床环境中的现状和未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/2fdd6e66347c/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/721d36a850d4/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/49193635f47b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/f07e285603d8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/2598cb0db62e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/56e560b43a02/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/abaca8056a46/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/08c15a98d27f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/b1b01167dda5/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/2fdd6e66347c/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/721d36a850d4/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/49193635f47b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/f07e285603d8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/2598cb0db62e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/56e560b43a02/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/abaca8056a46/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/08c15a98d27f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/b1b01167dda5/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b943/12018049/2fdd6e66347c/gr8.jpg

相似文献

[1]
Poloxamer-based drug delivery systems: Frontiers for treatment of solid tumors.

Mater Today Bio. 2025-4-2

[2]
Advances in the therapeutic delivery and applications of functionalized Pluronics: A critical review.

Adv Colloid Interface Sci. 2022-1

[3]
Poloxamer: A versatile tri-block copolymer for biomedical applications.

Acta Biomater. 2020-7-1

[4]
Emerging Treatment Options of Pluronic in Designing Colloidal Nano and Micro Carriers for Various Therapies.

Recent Pat Nanotechnol. 2025

[5]
Polymeric Drug Delivery System Based on Pluronics for Cancer Treatment.

Molecules. 2021-6-12

[6]
Poloxamer Hydrogels for Biomedical Applications.

Pharmaceutics. 2019-12-10

[7]
Pluronics and MDR reversal: an update.

Mol Pharm. 2014-8-4

[8]
Thermogelling properties of purified poloxamer 407.

Heliyon. 2017-8-30

[9]
Formulation of benzoporphyrin derivatives in Pluronics.

Photochem Photobiol. 2003-3

[10]
Polymeric Aggregates in Ionic Liquids: The Green Future of the Delivery Systems.

Curr Drug Targets. 2015

引用本文的文献

[1]
Advancements in Hydrogels: A Comprehensive Review of Natural and Synthetic Innovations for Biomedical Applications.

Polymers (Basel). 2025-7-24

[2]
Dual-loaded niosome-dendrimer nanoplatform enhances Tirapazamine delivery to hypoxic breast cancer cells.

Sci Rep. 2025-8-11

[3]
Hyaluronic acid-modified theranostic niosomes for targeted Fingolimod delivery and inhibition of triple-negative breast cancer metastasis.

Med Oncol. 2025-6-12

本文引用的文献

[1]
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy.

Mater Today Bio. 2025-3-1

[2]
Dual-stage Acting Dendrimeric Nanoparticle for Deepened Chemotherapeutic Drug Delivery to Tumor Cells.

Adv Pharm Bull. 2024-10

[3]
Sprayable anti-adhesive hydrogel for peritoneal macrophage scavenging in post-surgical applications.

Nat Commun. 2024-9-27

[4]
Recent advances of injectable in situ-forming hydrogels for preventing postoperative tumor recurrence.

Drug Deliv. 2024-12

[5]
Immunotherapy in Breast Cancer.

Int J Mol Sci. 2024-7-9

[6]
Metabolic adaptations in prostate cancer.

Br J Cancer. 2024-11

[7]
Epidemiology of Uterine Cancer in Sarawak, Borneo, A 20-Year Review.

Asian Pac J Cancer Prev. 2024-4-1

[8]
An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives.

J Drug Target. 2024-7

[9]
The Lancet Commission on prostate cancer: planning for the surge in cases.

Lancet. 2024-4-27

[10]
Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment.

NPJ Precis Oncol. 2024-3-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索